No Data
Rakovina Therapeutics Up as Announces "Key Milestone" In Cancer Drug Innovation
Rakovina Therapeutics Announces Receipt of AI-Derived Drug Candidates and Advancement to Preclinical Validation
Rakovina Therapeutics to Connect With Industry Leaders During 43rd Annual J.P. Morgan Healthcare Conference Week
Rakovina Therapeutics: Reflecting on 2024 Success and Building Momentum for a Transformative 2025
Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
Rakovina Therapeutics Expands Funding for Cancer Research
No Data